Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

AMED news

AMED news - Detail

2019.04.30: Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

A press release from the Japan Agency for Medical Research and Development (AMED):

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

Visit AMED website

Back to List